Loading...
XSHG
600566
Market cap3.27bUSD
Jul 09, Last price  
24.10CNY
1D
1.30%
1Q
-4.10%
Jan 2017
-22.90%
IPO
50.16%
Name

Hubei Jumpcan Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600566 chart
P/E
12.49
P/S
3.57
EPS
1.93
Div Yield, %
8.67%
Shrs. gr., 5y
1.99%
Rev. gr., 5y
0.17%
Revenues
6.22b
-22.43%
200,716,165218,550,423212,985,977222,018,131237,141,110240,469,8211,920,133,4862,447,577,6102,986,412,1543,767,836,3734,677,891,5605,642,009,1387,208,205,7886,939,993,8116,164,974,1667,630,510,0008,996,366,9789,654,537,1918,016,894,7556,218,642,450
Net income
1.78b
-29.77%
9,726,89510,875,6988,379,4787,708,5208,462,6997,916,482237,670,935402,723,955519,392,601686,571,189934,182,9461,223,463,5151,687,863,2651,622,973,8971,277,212,4881,719,175,9342,170,749,9282,822,781,1672,531,554,0611,777,852,640
CFO
1.20b
-44.94%
4,242,18536,720,00023,053,3624,917,24851,128,274411,23727,010,322287,164,897616,112,024645,475,175913,095,3891,188,750,4191,709,147,3192,147,676,1121,781,691,1631,894,329,3922,620,832,8793,463,958,6322,176,437,0151,198,294,243
Dividend
Jun 30, 20252.09 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
IPO date
Aug 22, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT